Cenyx Biotech Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$8.38M
- Investors
-
17
Cenyx Biotech General Information
Description
Developer of a cerium oxide-based nanozyme therapeutic designed to treat acute and chronic inflammatory diseases. The company offers enzyme-mimetic nanoparticles that catalytically eliminate reactive oxygen species, enabling patients suffering from conditions such as subarachnoid hemorrhage and acute kidney injury to improve management of inflammation-related damage.
Contact Information
Website
www.cenyxbiotech.comCorporate Office
- 2th Floor
- 20 Seongsu-iro 7-gil, Seongdong-gu
- Seoul, 04781
- South Korea
Corporate Office
- 2th Floor
- 20 Seongsu-iro 7-gil, Seongdong-gu
- Seoul, 04781
- South Korea
Cenyx Biotech Timeline
Cenyx Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 31-Mar-2026 | $8.38M | Completed | Clinical Trials - Phase 1 | ||
| 5. Grant | 15-Oct-2025 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 01-Apr-2025 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC (Series A) | 30-Apr-2021 | Completed | Clinical Trials - Phase 1 | |||
| 2. Grant | 01-Mar-2020 | $1.34M | $3.37M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 09-Aug-2019 | $3.37M | $3.37M | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cenyx Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cenyx Biotech Patents
Cenyx Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026151308-A1 | Novel cerium oxide nanocomposite and composition for preventing or treating kidney diseases comprising same | Pending | 10-Jan-2025 | ||
| WO-2025264026-A1 | Novel cerium oxide nanocomposite comprising lysine and uses thereof | Pending | 20-Jun-2024 | ||
| AU-2024296025-A1 | Novel cerium oxide nanocomposite with enhanced biostability and use thereof | Pending | 13-Jul-2023 | ||
| EP-4744682-A1 | Novel cerium oxide nanocomposite with enhanced biostability and use thereof | Pending | 13-Jul-2023 | ||
| WO-2025014319-A1 | Novel cerium oxide nanocomposite with enhanced biostability and use thereof | Inactive | 13-Jul-2023 | A61K47/6933 |
Cenyx Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cenyx Biotech Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kiwoom Investment | Venture Capital | Minority | ||
| ScaleUP Ventures | Venture Capital | Minority | ||
| Tipa(Korea Technology and Information Promotion Agency for SMEs) | Corporation | |||
| Korea Drug Development Fund | Corporation | |||
| Albatross Investment | Venture Capital | Minority |
Cenyx Biotech FAQs
-
When was Cenyx Biotech founded?
Cenyx Biotech was founded in 2016.
-
Where is Cenyx Biotech headquartered?
Cenyx Biotech is headquartered in Seoul, South Korea.
-
What is the size of Cenyx Biotech?
Cenyx Biotech has 36 total employees.
-
What industry is Cenyx Biotech in?
Cenyx Biotech’s primary industry is Drug Discovery.
-
Is Cenyx Biotech a private or public company?
Cenyx Biotech is a Private company.
-
What is Cenyx Biotech’s current revenue?
The current revenue for Cenyx Biotech is .
-
How much funding has Cenyx Biotech raised over time?
Cenyx Biotech has raised $28.3M.
-
Who are Cenyx Biotech’s investors?
Kiwoom Investment, ScaleUP Ventures, Tipa(Korea Technology and Information Promotion Agency for SMEs), Korea Drug Development Fund, and Albatross Investment are 5 of 17 investors who have invested in Cenyx Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
